Arcturus Therapeutics Holdings (ARCT) Enterprise Value (2018 - 2025)
Historic Enterprise Value for Arcturus Therapeutics Holdings (ARCT) over the last 8 years, with Q3 2025 value amounting to -$235.4 million.
- Arcturus Therapeutics Holdings' Enterprise Value rose 1944.64% to -$235.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$235.4 million, marking a year-over-year increase of 1944.64%. This contributed to the annual value of -$292.0 million for FY2024, which is 1629.8% up from last year.
- Latest data reveals that Arcturus Therapeutics Holdings reported Enterprise Value of -$235.4 million as of Q3 2025, which was up 1944.64% from -$251.5 million recorded in Q2 2025.
- In the past 5 years, Arcturus Therapeutics Holdings' Enterprise Value ranged from a high of -$235.4 million in Q3 2025 and a low of -$466.8 million during Q1 2021
- Moreover, its 5-year median value for Enterprise Value was -$319.7 million (2022), whereas its average is -$327.1 million.
- Its Enterprise Value has fluctuated over the past 5 years, first crashed by 68498.6% in 2021, then surged by 4257.37% in 2022.
- Over the past 5 years, Arcturus Therapeutics Holdings' Enterprise Value (Quarter) stood at -$370.5 million in 2021, then fell by 5.77% to -$391.9 million in 2022, then increased by 10.97% to -$348.9 million in 2023, then increased by 16.3% to -$292.0 million in 2024, then rose by 19.4% to -$235.4 million in 2025.
- Its last three reported values are -$235.4 million in Q3 2025, -$251.5 million for Q2 2025, and -$255.4 million during Q1 2025.